Company Snapshot
Central District
Kibbutz Glil Yam, 4690500
Israel
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full Time Employees: 153
Please select from the dropdown
Company Financials

2018
2019
2020
Gross Profit
$10,468,000
Operating Income
-$124,905
-$117,426
-$8,245,000
Net Income
-$124,970
-$122,668
-$28,698,000
2018
Gross Profit
Operating Income
-$124,905
Net Income
-$124,970
2019
Gross Profit
Operating Income
-$117,426
Net Income
-$122,668
2020
Gross Profit
$10,468,000
Operating Income
-$8,245,000
Net Income
-$28,698,000
The above data on IM Cannabis Corp came from annual proxy statements to the SEC. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov
Top Executives
Total Cash info
Equity info
Other info
Total Compensation
Top Executives
Total Compensation
Executive Chairman of the Board
$90,000
$1,059,085
$500,000
$1,649,085
$1,649,085
Executive Chairman of the Board
Director and Chief Executive Officer
$534,492
$202,743
$4,577
$741,812
$741,812
Director and Chief Executive Officer
Chief Financial Officer
$324,960
$112,390
$0
$437,350
$437,350
Chief Financial Officer
IM Cannabis Corp listed the above executives on its annual proxy statement to the SEC for the fiscal year of 2020. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov

The sum of all cash payments made to an individual for services during a given year. It is comprised of yearly Base Pay and Bonuses

To view more detailed proxy data including previous years contact our sales team.

Contact Us

The value of stock and option awards plus long term incentives granted.

To view more detailed proxy data including previous years contact our sales team.

Contact Us

This covers all compensation that don't fit in any of these other standard categories

To view more detailed proxy data including previous years contact our sales team.

Contact Us